Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
The FDA-approved answer is yes3
Josh Lichtman, medical director at Neuro Wellness Spa, not involved in the study, commented on the research for MNT
Interestingly, while inhibition of MEK by PD98059 effectively suppressed ERK1/2 activation, reduced p-ERK1/2 expression levels, and alleviated the EMT process, TB001 did not affect ERK1/2 signaling pathway ( Figure 8E ), aligning with the immunohistochemistry results in kidney grafts